-
Former Arsenal, Spain midfielder Cazorla retires
-
Spain, Portugal eye World Cup last 16
-
German drone maker raises $1.2 bn as investors pile into defence
-
Russian strikes kill 17 in biggest ever attack on Kyiv, mayor says
-
French scramble to find air conditioners before next heatwave
-
Uruguay veteran Cavani quits Boca Juniors
-
Japan deploys bear cameras in moutains as attacks surge
-
West Ham's Fernandes joins Spurs
-
Germany's Infineon opens major chip plant as EU seeks tech autonomy
-
Bones of contention: More research needed on 'd'Artagnan corpse'
-
Biggest ever Russian barrage on Kyiv kills at least 13
-
Coffee with a view: tourists flock to Starbucks overlooking North Korea
-
EU top court upholds record 4.1 bn euro Google fine
-
German coalition agrees on reform package in key breakthrough
-
Italy name two debutants to face Japan in Nations Championship opener
-
France recall record try scorer Penaud for All Blacks Test
-
Wallabies' Schmidt rules out another coaching job
-
Seoul's Kospi tanks as Asia tech firms suffer another blow
-
India asks Meta to hold WhatsApp username rollout over fraud fears
-
'Outstanding' Love to start at fly-half for All Blacks against France
-
Deadly Russian barrage on Kyiv kills at least 13
-
Campbell back from four years in Wallabies wilderness to face Ireland
-
Next indirect US-Iran talks after Khamenei funeral: mediators
-
Migrants pick up pieces back home after fleeing South Africa
-
Reviving Montenegro's 'ancient' olive tree
-
Farrell names Leinster-heavy Ireland side to face Wallabies
-
Resource rich PNG leaving its Pacific people behind: World Bank
-
Fearing Russian strike, Kyiv's Holodomor museum evacuates exhibits
-
Papal envoy presides over first Vietnam beatification rite
-
Germany's energy-hungry small firms struggle with green shift
-
LeBron James praises Balogun after 'Silencer' celebration
-
Pochettino says Balogun foul 'never' a red card as suspension looms
-
Farrell names Leinster-heavy side to face Wallabies
-
Campbell back after four years in Wallabies team to face Ireland
-
Most Asia markets down as tech firms take fresh blow
-
Kane saves England as USA, Belgium reach last 16
-
South Korean school baseball team suspended over 'Tank Day' chants
-
Budding chefs cook up new career at China's BBQ academy
-
Ceuzany, Cape Verde's golden voice with volcanic emotion
-
One stitch at a time: Artist's mission to recreate the Bayeux Tapestry
-
Balogun scores and sees red as US beat Bosnia 2-0
-
Deadly Russian barrage pounds Ukraine capital
-
EU top court to rule on record 4.1 bn euro Google fine
-
Belgium coach salutes Tielemans after World Cup rescue act
-
'Job forever': trade schools are all the rage in the AI era
-
Cracking open a can of cannabis -- America's new pastime (for now)
-
Celtics reportedly trading Brown to Sixers in NBA blockbuster
-
Russia strikes Ukraine capital with missiles and drones, wounds five
-
IRS Form 2290 Filing Window Now Open for 2026-27 Tax Period; Stay HVUT Compliant with EZ2290
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 02
Food or medicine? Stark choice for sick Argentines
In pharmacies in crisis-riddled Argentina, people look at the prices on medicine containers, then put them down again.
Even prescription antibiotics and chronic treatments are being ditched in a country where annual inflation exceeding 250 percent means that healthcare has become a luxury for many.
"Between eating and buying medicine, people choose to eat," pharmacist Marcela Lopez told AFP from behind her counter in the capital, Buenos Aires.
Medicine sales in the country dropped by 10 million units -- bottles or boxes -- in the month of January, according to the Ceprofar pharmacists' association. More than two-thirds were prescription drugs.
Desperate patients also feel abandoned by the public health system, where many medicines have become unavailable since the government of President Javier Milei, who took office in December, ordered an audit as part of his quest to slash public spending.
Viviana Bogado, a 53-year-old cook, said she had to choose between treatment for her cholesterol and antibiotics and special food for her 16-year-old son, Daniel, for an intestinal bacteria.
She put her son first.
Since self-styled "anarcho-capitalist" Milei took over, medicine prices have risen 40 percent above inflation, itself at 254 percent year-on-year and one of the highest in the world.
At the same time, poverty levels have reached nearly 60 percent in a country where the minimum salary is the equivalent of about $200.
According to Ceprofar director Ruben Sajem, there had been an agreement between laboratories and the pre-Milei government to keep prices low.
That has since been abandoned.
- 'There is no money' -
Pharmacists say many chronic patients were reducing their prescription doses to try and save money.
"This does not serve the patient. Sooner or later their health will worsen and everything will cost more, even for the (public) health system," said Sajem.
Worst hit are retired Argentines and workers in the informal sector, who account for 40 percent of the labor market.
The state pension devalued by a third year-on-year in February, making life difficult for people like 73-year-old Graciela Fuentes, who is having a hard time treating her arthritis.
The state provides pensioners with some medicines for free, others at subsidized prices.
"I take five remedies: two of which I get free of charge, I spend 85,000 pesos per month (about $100) -- almost a third of my pension. There is no money," said Fuentes in an ironic reference to Milei's oft-used justification for public spending cuts.
Fabian Furman, the head of a community medicines bank run by a Jewish foundation, told AFP there had been a massive increase in demand for free treatments.
- 'Pablo has no time' -
Pablo Riveros, 20, suffers from paroxysmal nocturnal hemoglobinuria, a rare, life-threatening disease for which there is no cure.
The treatment to alleviate his fast-worsening symptoms costs $42,000 a month, an impossible ask from his seamstress mother.
After his diagnosis in February last year, Riveros received medication from the public healthcare system. But that stopped in November.
Riveros's family went to court seeking relief, and were told "the state is not denying us medication, but we have to wait for the audit," his mother Estela Coronel told AFP.
The only problem, "Pablo has no time" to wait, weakening by the day.
Presidential spokesman Manuel Adorni last week denied that drug delivery to patients with cancer and other serious diseases such as Riveros had ever been cut off.
"It’s painful because you feel like they're laughing in your face," said Coronel.
"They cannot deny something that we are living."
T.Wright--AT